Safety and immunogenicity of a recombinant live attenuated tetravalent dengue vaccine (DENVax) in flavivirus-naive healthy adults in Colombia: a randomised, placebo-controlled, phase 1 study (Q36288109)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and immunogenicity of a recombinant live attenuated tetravalent dengue vaccine (DENVax) in flavivirus-naive healthy adults in Colombia: a randomised, placebo-controlled, phase 1 study |
scientific article |
Statements
1 reference
Safety and immunogenicity of a recombinant live attenuated tetravalent dengue vaccine (DENVax) in flavivirus-naive healthy adults in Colombia: a randomised, placebo-controlled, phase 1 study (English)
1 reference
Jorge E Osorio
1 reference
Janae L Stovall
1 reference
Ivan D Velez
1 reference
Cynthia Thomson
1 reference
Liliana Lopez
1 reference
Alejandra Jimenez
1 reference
Aurelia A Haller
1 reference
Shawn Silengo
1 reference
Jaclyn Scott
1 reference
Karen L Boroughs
1 reference
Betty E Luy
1 reference
John Arguello
1 reference
Mark E Beatty
1 reference
Joseph Santangelo
1 reference
Gilad S Gordon
1 reference
Claire Y-H Huang
1 reference
1 reference
Identifiers
1 reference